Document, Jointly Developed by OHRP and FDA, Is Open for Comments Until April 30
Darla M. Fera
March 5, 2024 at 08:15:35 ET
The Department of Health and Human Services (HHS) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) have posted for stakeholder comments a draft guidance entitled “Key Information and Facilitating Understanding in Informed Consent,” which addresses provisions of the revised Common Rule that prescribe informed consent in clinical research, includ...
Read More